Published • loading... • Updated
Health Slows Down the Drug Kisunla for Alzheimer because of Its Cost-Effectiveness
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
On Wednesday, the Ministry of Health published the full document of the agreements reached by the Inter-Ministerial Commission on Drug Prices (CIPM) at its meeting in March. The novelties, taking into account that the medicines that received the green light to be included in public funding were already known, are the drugs that have been 'raped'. In this case there are three. One of them is Kisunla, a drug aimed at the treatment of alzhéimer, wh…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
